Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7787]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
ASH 2016: AML, CLL and leukaemogenesis latest
Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA
ASH 2016: AML, CLL and leukaemogenesis latest ( Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA )
5 Dec 2016
Ineligibility required for 'anti-trials': inclusion in studies regardless of...
Prof Guillermo Garcia-Manero - MD Anderson Cancer Center, Houston, USA
Ineligibility required for 'anti-trials': inclusion in studies regardless of fitness ( Prof Guillermo Garcia-Manero - MD Anderson Cancer Center, Houston, USA )
5 Dec 2016
Vosaroxin for relapsed AML: Updates from VALOR
Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA
Vosaroxin for relapsed AML: Updates from VALOR ( Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA )
5 Dec 2016
Impact of next-generation sequencing on treatment choice for MDS
Dr Ana Alfonso Pierola - MD Anderson Cancer Center, Houston, USA
Impact of next-generation sequencing on treatment choice for MDS ( Dr Ana Alfonso Pierola - MD Anderson Cancer Center, Houston, USA )
4 Dec 2016
Obinutuzumab extends PFS for follicular lymphoma in GALLIUM trial
Dr Andrew Davies - University of Southampton, Southampton, UK
Obinutuzumab extends PFS for follicular lymphoma in GALLIUM trial ( Dr Andrew Davies - University of Southampton, Southampton, UK )
4 Dec 2016
Venetoclax plus cytarabine in elderly AML patients
Dr Andrew Wei - Alfred Hospital, Melbourne, Australia
Venetoclax plus cytarabine in elderly AML patients ( Dr Andrew Wei - Alfred Hospital, Melbourne, Australia )
4 Dec 2016
Intravenous or subcutaenous rituximab for FL in the SABRINA study
Dr Andrew Davies - University of Southampton, Southampton, UK
Intravenous or subcutaenous rituximab for FL in the SABRINA study ( Dr Andrew Davies - University of Southampton, Southampton, UK )
4 Dec 2016
Ibrutinib in CLL: RESONATE and resistance
Dr Jennifer Woyach - The Ohio State University Medical Center, Columbus, USA
Ibrutinib in CLL: RESONATE and resistance ( Dr Jennifer Woyach - The Ohio State University Medical Center, Columbus, USA )
4 Dec 2016
Large granular lymphocyte proliferations in MDS
Dr Christa Roe - H. Lee Moffitt Cancer Center, Tampa, USA
Large granular lymphocyte proliferations in MDS ( Dr Christa Roe - H. Lee Moffitt Cancer Center, Tampa, USA )
4 Dec 2016
Durable remissions with the VcR-CVAD regimen for MCL regardless of age
Dr Julie Chang - University of Wisconsin Hospital and Clinics, Madison, USA
Durable remissions with the VcR-CVAD regimen for MCL regardless of age ( Dr Julie Chang - University of Wisconsin Hospital and Clinics, Madison, USA )
4 Dec 2016
TKI cessation for CML patients with deep molecular response: an update from the...
Dr Francois-Xavier Mahon - Université Bordeaux, Bordeaux, France
TKI cessation for CML patients with deep molecular response: an update from the EURO-SKI trial ( Dr Francois-Xavier Mahon - Université Bordeaux, Bordeaux, France )
3 Dec 2016
Tailoring therapy for leukaemia patients
Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA
Tailoring therapy for leukaemia patients ( Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA )
3 Dec 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation